549 related articles for article (PubMed ID: 31196727)
21. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study.
Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G
Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487
[TBL] [Abstract][Full Text] [Related]
22. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.
Kezuka T; Ishikawa H
Jpn J Ophthalmol; 2018 Mar; 62(2):101-108. PubMed ID: 29445944
[TBL] [Abstract][Full Text] [Related]
24. Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients.
Deschamps R; Lecler A; Lamirel C; Aboab J; Gueguen A; Bensa C; Vignal C; Gout O
Eur J Neurol; 2017 Jun; 24(6):875-879. PubMed ID: 28477397
[TBL] [Abstract][Full Text] [Related]
25. [Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis].
Song HL; Wei SH
Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):174-179. PubMed ID: 30841683
[No Abstract] [Full Text] [Related]
26. Comparing myelin oligodendrocyte glycoprotein antibody (MOG-Ab) and non MOG-Ab associated optic neuritis: Clinical course and treatment outcome.
Etemadifar M; Abbasi M; Salari M; Etemadifar F; Tavakoli H
Mult Scler Relat Disord; 2019 Jan; 27():127-130. PubMed ID: 30368225
[TBL] [Abstract][Full Text] [Related]
27. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
[TBL] [Abstract][Full Text] [Related]
28. Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.
Jelcic I; Hanson JVM; Lukas S; Weber KP; Landau K; Pless M; Reindl M; Weller M; Martin R; Lutterotti A; Schippling S
J Neuroophthalmol; 2019 Mar; 39(1):3-7. PubMed ID: 30015656
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection.
Sun CB
Front Immunol; 2023; 14():1296518. PubMed ID: 38054007
[TBL] [Abstract][Full Text] [Related]
30. Clinical Profile of Anti-Myelin Oligodendrocyte Glycoprotein Antibody Seropositive Cases of Optic Neuritis.
Matsuda R; Kezuka T; Umazume A; Okunuki Y; Goto H; Tanaka K
Neuroophthalmology; 2015 Oct; 39(5):213-219. PubMed ID: 27928358
[TBL] [Abstract][Full Text] [Related]
31. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
[TBL] [Abstract][Full Text] [Related]
32. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.
Ambika S; Durgapriyadarshini S; Padmalakshmi K; Noronha V; Arjundas D
Indian J Ophthalmol; 2022 Jan; 70(1):194-200. PubMed ID: 34937238
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous bilateral optic neuritis in China: clinical, serological and prognostic characteristics.
Kang H; Liu Z; Li H; Chen T; Ai N; Xu Q; Cao S; Tao Y; Wei S
Acta Ophthalmol; 2019 May; 97(3):e426-e434. PubMed ID: 30632682
[TBL] [Abstract][Full Text] [Related]
34. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
[TBL] [Abstract][Full Text] [Related]
36. Acute idiopathic optic neuritis: not always benign.
Deschamps R; Gueguen A; Lecler A; Lecouturier K; Lamirel C; Bensa C; Marignier R; Vignal C; Gout O
Eur J Neurol; 2018 Nov; 25(11):1378-1383. PubMed ID: 30004610
[TBL] [Abstract][Full Text] [Related]
37. Glial autoantibody prevalence in Chinese optic neuritis with onset after age 45: clinical factors for diagnosis.
Song H; Chuai Y; Yang M; Zhou H; Sun M; Xu Q; Wei S
Front Immunol; 2023; 14():1181908. PubMed ID: 37705973
[TBL] [Abstract][Full Text] [Related]
38. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.
Cobo-Calvo A; Ruiz A; Maillart E; Audoin B; Zephir H; Bourre B; Ciron J; Collongues N; Brassat D; Cotton F; Papeix C; Durand-Dubief F; Laplaud D; Deschamps R; Cohen M; Biotti D; Ayrignac X; Tilikete C; Thouvenot E; Brochet B; Dulau C; Moreau T; Tourbah A; Lebranchu P; Michel L; Lebrun-Frenay C; Montcuquet A; Mathey G; Debouverie M; Pelletier J; Labauge P; Derache N; Coustans M; Rollot F; De Seze J; Vukusic S; Marignier R;
Neurology; 2018 May; 90(21):e1858-e1869. PubMed ID: 29695592
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and disease course in aquaporin-4 antibody-positive Chinese patients with acute optic neuritis.
Kang H; Chen T; Li H; Xu Q; Cao S; Wei S
J Neurol; 2017 Oct; 264(10):2130-2140. PubMed ID: 28879451
[TBL] [Abstract][Full Text] [Related]
40. Different magnetic resonance imaging features between MOG antibody- and AQP4 antibody-mediated disease: A Chinese cohort study.
Chen C; Liu C; Fang L; Zou Y; Ruan H; Wang Y; Cui C; Sun X; Peng L; Qiu W
J Neurol Sci; 2019 Oct; 405():116430. PubMed ID: 31465985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
